Newsflash #517

FreeStyle Navigator® Continuous Glucose Monitoring System is experiencing a supply interruption and has been unable to provide patients with replacement receivers and transmitters and cannot estimate when the supply of the FreeStyle Navigator Continuous Glucose Monitoring System will resume.

The US Food and Drug Administration (FDA) has approved the first generic formulations of losartan potassium tablets, alone (Cozaar, Merck) and in combination with hydrochlorothiazide (Hyzaar, Merck), for the treatment of hypertension.

Roche acquires Medingo, Ltd., manufacturer of the Solo Insulin Dispensing Patch (Solo4You.com).